PMID- 19735383 OWN - NLM STAT- MEDLINE DCOM- 20100107 LR - 20220318 IS - 1365-3148 (Electronic) IS - 0958-7578 (Linking) VI - 19 IP - 6 DP - 2009 Dec TI - The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. PG - 315-28 LID - 10.1111/j.1365-3148.2009.00933.x [doi] AB - This study provides data on National Blood Service (NBS) red blood cell (RBC, n = 9142), platelet (PLT, n = 4232) and fresh frozen plasma (FFP, n = 3584) recipients independently sampled by monthly quota from 29 representative hospitals over 12 months in 2001-2002. Hospitals were stratified by size according to total yearly RBC issues. Transfusion indications were chosen from diagnostic and procedural codes, and recipients grouped into Epidemiology and Survival of Transfusion Recipients Case-mix Groups (E-CMGs). The main E-CMGs were digestive [19% of RBC recipients; including 5% gastrointestinal (GI) bleeds and 3% colorectal surgery], musculoskeletal (15%; 12% hip and knee replacement), haematology (13%) and obstetrics and gynaecology (10%). Renal failure, fractured neck of femur, cardiac artery by-pass grafting (CABG) and paediatrics, each accounted for 3-4% recipients. FFP recipients: the main E-CMGs were digestive (21% of FFP recipients; including 7% GI bleeds and 3% colorectal surgery), hepatobiliary (15%; 7% liver disease and 2% liver transplant), cardiac (12%) and paediatrics (9%) The renal, paediatrics, vascular and haematology E-CMGs each had 6-7% of recipients. PLT recipients: the main E-CMGs were haematology (27% of PLT recipients; including 9% lymphoma and 8% acute leukaemia), cardiac (17%), paediatrics (13%), hepatobiliary (10%) and digestive (9%). Back-weighting gave national estimates of 433 000 RBC, 57 500 FFP and 41 500 PLT recipients/year in England and North Wales, median age 69, 64 and 59 years, respectively. Digestive and hepatobiliary indications emerged as the top reason for transfusion in RBC and FFP recipients, and was also a frequent indication in PLT recipients. FAU - Wells, A W AU - Wells AW AD - NHS Blood and Transplant (NHSBT), Newcastle upon Tyne, UK. angus.wells@nhsbt.nhs.uk FAU - Llewelyn, C A AU - Llewelyn CA FAU - Casbard, A AU - Casbard A FAU - Johnson, A J AU - Johnson AJ FAU - Amin, M AU - Amin M FAU - Ballard, S AU - Ballard S FAU - Buck, J AU - Buck J FAU - Malfroy, M AU - Malfroy M FAU - Murphy, M F AU - Murphy MF FAU - Williamson, L M AU - Williamson LM LA - eng GR - MC_U122870183/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20090903 PL - England TA - Transfus Med JT - Transfusion medicine (Oxford, England) JID - 9301182 SB - IM MH - Blood Banks MH - Blood Transfusion/*statistics & numerical data MH - England MH - Erythrocyte Transfusion MH - Hemorrhage/pathology/*therapy MH - Hospitals/*statistics & numerical data MH - Humans MH - Plasma MH - Platelet Transfusion MH - Retrospective Studies MH - Wales EDAT- 2009/09/09 06:00 MHDA- 2010/01/08 06:00 CRDT- 2009/09/09 06:00 PHST- 2009/09/09 06:00 [entrez] PHST- 2009/09/09 06:00 [pubmed] PHST- 2010/01/08 06:00 [medline] AID - TME933 [pii] AID - 10.1111/j.1365-3148.2009.00933.x [doi] PST - ppublish SO - Transfus Med. 2009 Dec;19(6):315-28. doi: 10.1111/j.1365-3148.2009.00933.x. Epub 2009 Sep 3.